Preferred Label : Oxaliplatin;

MeSH definition : An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.;

MeSH synonym : 1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II); Platinum(II)-1,2-cyclohexanediamine Oxalate; Oxalato-(1,2-cyclohexanediamine)platinum II; Oxaliplatin, (SP-4-2-(1R-trans))-isomer; Oxaliplatine; 1,2-Diaminocyclohexane Platinum Oxalate; 1,2 Diaminocyclohexane Platinum Oxalate; L-OHP Cpd; Platinum(2 ) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1);

MeSH hyponym : ACT-078; ACT078;

MeSH CAS label : Platinum(2 ) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1);

MeSH Related Number : 61758-77-8 ((SP-4-2-(1S-trans))-isomer); 61913-68-6 ((SP-4-3-(cis))-isomer);

UNII : 04ZR38536J;

Details


Main resources

You can consult :

An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.

https://www.cochrane.org/fr/CD010885/CHILDCA_differentes-durees-de-perfusion-pour-prevenir-la-perte-daudition-induite-par-le-platine-chez-les
2020
false
false
false
France
United Kingdom
French
review of literature
cisplatin
carboplatin
antineoplastic agents
organoplatinum compounds
hearing loss
hearing loss
drug administration schedule
child
neoplasms
infusions, intravenous
french abstract
treatment outcome
Oxaliplatin

---
https://ansm.sante.fr/informations-de-securite/Mesures-de-precaution-pour-limiter-le-risque-de-maladie-veino-occlusive-hepatique-MVO-chez-les-patients-atteints-de-lymphome-et-recevant-une-autogreffe
2018
false
false
false
France
French
hepatic veno-occlusive disease
risk
transplantation, autologous
hematopoietic stem cell transplantation
lymphoma, Non-Hodgkin
pharmacovigilance note
hepatic veno-occlusive disease
antineoplastic combined chemotherapy protocols
antineoplastic agents
continuity of patient care
liver function tests
R-DHAOx
cytarabine
dexamethasone
Rituximab
organoplatinum compounds
Oxaliplatin

---
http://www.has-sante.fr/portail/jcms/c_2744493/fr/oxaliplatine-sun
2017
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
organoplatinum compounds
Oxaliplatin

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/951
2014
false
false
false
Canada
French
journal article
oxaliplatin
antineoplastic agents
antineoplastic agents
peripheral nervous system diseases
antineoplastic combined chemotherapy protocols
antineoplastic combined chemotherapy protocols
Sensory neuropathy
organoplatinum compounds
organoplatinum compounds
Oxaliplatin
Oxaliplatin

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/951/612
2014
false
false
false
Canada
French
journal article
effective
disorder of the peripheral nervous system, nos
grade, nos
oxaliplatin
social adjustment
nervous system diseases
quebec
adjustment, nos
Tables
Tables
organoplatinum compounds
Oxaliplatin

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO_-_Hypersensibilite_sels_platine_taxanes(2013-07-24).pdf
2013
false
false
Canada
French
drug hypersensitivity
antineoplastic agents
review of literature
cisplatin
carboplatin
paclitaxel
organoplatinum compounds
taxoids
platinum salt, nos
neoplasms
algorithms
practice guideline
Docetaxel
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65564194
2012
France
summary of product characteristics
package leaflet
oxaliplatin
powders
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67228961
2012
France
summary of product characteristics
package leaflet
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64372262
2012
France
summary of product characteristics
package leaflet
oxaliplatin
powders
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65677167
2012
France
summary of product characteristics
package leaflet
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64101179
2012
France
summary of product characteristics
package leaflet
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65777819
2012
France
summary of product characteristics
package leaflet
powders
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67127720
2012
France
summary of product characteristics
package leaflet
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69699620
2012
France
summary of product characteristics
package leaflet
powders
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69634537
2012
France
summary of product characteristics
package leaflet
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66061299
2012
France
summary of product characteristics
package leaflet
oxaliplatin
powders
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62345640
2012
France
summary of product characteristics
package leaflet
oxaliplatin
powders
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68687558
2012
France
summary of product characteristics
package leaflet
powders
oxaliplatin
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60598520
2012
France
summary of product characteristics
package leaflet
oxaliplatin
powders
Oxaliplatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68402653
2012
France
summary of product characteristics
package leaflet
powders
oxaliplatin
Oxaliplatin

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00051
2009
false
Canada
English
French
treatment outcome
drug evaluation, preclinical
oxaliplatin
organoplatinum compounds
organoplatinum compounds
antineoplastic agents
antineoplastic agents
canada
drug approval
infusions, intravenous
antineoplastic combined chemotherapy protocols
neoplasm metastasis
colorectal neoplasms
organoplatinum compounds
drug information
Oxaliplatin
Oxaliplatin

---
https://pgtmsite.files.wordpress.com/2024/01/oxaliplatine_ad_et_rum_20070515.pdf
2007
Canada
drug information
Analyzed
Use
Oxaliplatin
Analysis
Oxaliplatin
Review

---
https://pgtmsite.files.wordpress.com/2024/01/oxaliplatine_colonadjuvant_pgtm_20050930.pdf
2005
Canada
drug information
cancer of colon
Oxaliplatin
Adjuvant
neoplasm, malignant
Adjuvant Therapy Clinical Trial Setting
Oxaliplatin
large intestine, nos
colonic neoplasms
Colon Carcinoma
Additive
Adjudicator
adjuvant, nos

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.